Vasilios Liapis
North Terrace
Adelaide, SA 5000, Australia
Adelaide, SA 5000, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Detection of immune-mediated tumour cell death in vivo using Zirconium-89-labeled APOMAB®.
Journal: Journal of translational medicine
Published: February 05, 2025
Antibody drug conjugates: hitting the mark in pancreatic cancer?
Journal: Journal of experimental & clinical cancer research : CR
Published: June 05, 2023
An anti-mesothelin targeting antibody drug conjugate induces pyroptosis and ignites antitumor immunity in mouse models of cancer.
Journal: Journal for immunotherapy of cancer
Published: February 21, 2023
Fc gamma receptor is not required for in vivo processing of radio- and drug-conjugates of the dead tumor cell-targeting monoclonal antibody, APOMAB®.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 07, 2022
Correction to: Positron Emission Tomographic Imaging of Tumor Cell Death Using Zirconium-89-Labeled APOMAB® Following Cisplatin Chemotherapy in Lung and Ovarian Cancer Xenograft Models.
Journal: Molecular imaging and biology
Published: August 16, 2021
The RNA-binding protein La/SSB associates with radiation-induced DNA double-strand breaks in lung cancer cell lines.
Journal: Cancer reports (Hoboken, N.J.)
Published: April 20, 2021
Positron Emission Tomographic Imaging of Tumor Cell Death Using Zirconium-89-Labeled APOMAB® Following Cisplatin Chemotherapy in Lung and Ovarian Cancer Xenograft Models.
Journal: Molecular imaging and biology
Published: March 04, 2021
Improved non-invasive positron emission tomographic imaging of chemotherapy-induced tumor cell death using Zirconium-89-labeled APOMAB®.
Journal: EJNMMI radiopharmacy and chemistry
Published: July 26, 2020
Tumour-associated macrophages process drug and radio-conjugates of the dead tumour cell-targeting APOMAB® antibody.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: June 01, 2020
APOMAB Antibody-Drug Conjugates Targeting Dead Tumor Cells are Effective In Vivo.
Journal: Molecular cancer therapeutics
Published: July 30, 2018
Anticancer efficacy of the hypoxia-activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma.
Journal: Cancer medicine
Published: January 09, 2017
Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment.
Journal: International journal of oncology
Published: October 18, 2016
Last Updated: 09/26/2026